The role of microalbuminuria and insulin resistance as significant risk factors for white matter lesions in Japanese type 2 diabetic patients

Current Medical Research and Opinion

Volumn 24, Issue 6, 2008, Pages 1561-1567

  Anan, Futoshi ^a   Masaki, Takayuki ^c   Iwao, Tetsu ^a   Eto, Takeshi ^a   Shimomura, Tsuyoshi ^a   Umeno, Yoshikazu ^a   Eshima, Nobuoki ^b   Saikawa, Tetsunori ^b   Yoshimatsu, Hironobu ^c  

^a OITA RED CROSS HOSPITAL   (Japan)

^b OITA UNIVERSITY   (Japan)

^c OITA UNIVERSITY   (Japan)

Author keywords

Insulin resistance; Microalbuminuria; Type 2 diabetes mellitus; White matter lesions

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; BRAIN DAMAGE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RISK FACTOR; WHITE MATTER;

AGED; ALBUMINURIA; BRAIN DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; STROKE;

EID: 46449093016     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007990802061818     Document Type: Article

References (33)

1. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. Stroke 1995;26:1293-301
2. Wong TY, Klein R, Sharrett AR, et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002;288:67-74
3. Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003;34:1126-9
4. Longstreth WT Jr, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996;27:1274-82
5. Schmidt R, Launer LJ, Nilsson LG, et al. CASCADE Consortium. A magnetic resonance imaging of midlife blood pressure to late-life cognitive decline and brain morphology. Diabetes 2004;53:687-92
6. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 1997;157:1413-18
7. Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 1999;42:263-85
8. Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-6
9. de Zeeuw D, Remuzzi G, Parving HH, et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004;110:921-7
10. Vupputuri S, Shoham DA, Hogan SL, et al. Microalbuminuria, peripheral artery disease, and cognitive function. Kidney Int 2008;73:341-6
11. Reaven GM. Role of insulin resistance in human disease. Diabetes 1998;37:1595-607
12. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94
13. Jeppesen J, Hansen TW, Rasmussen S, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol 2007;49:2112-19
14. Liao D, Sloan RP, Cascio WE, et al. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 1998;21:2116-22
15. Mancia G, De Backer G, Dominiczak A, et al. ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 2007;25:1751-62
16. Friedwald WT, Levi RI, Fredrickson DC. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1972;18:499-502
17. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19
18. Taniguchi A, Fukushima M, Sakai M, et al. Remnant-like particle cholesterol, triglyceride, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care 2000;23:1766-9
19. Taniwaki H, Nishizawa Y, Kawagishi T, et al. Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis. Diabetes Care 1998;21:1848-55
20. American Diabetes Association. Nephropathy in diabetes. Diabetes Care, 2004;27:S79-83
21. Breteler MM, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994;44:1246-52
22. Shimada K, Kawamoto A, Matsubayashi K, et al. Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension 1990;16:692-9
23. Sierra C, de la Sierra A, Mercader J, et al. Silent cerebral white matter lesions in middle-aged essential hypertensive patients. J Hypertens 2002;20:519-24
24. Goligorsky MS, Chen J, Brodsky S. Workshop: endothelial cell dysfunction leading to diabetic nephropathy: focus on nitric oxide. Hypertension 2001;37:744-8
25. Stout RW. Insulin and atheroma: 20-yr perspective. Diabetes Care 1990;13:631-54
26. Kuboki K, Jiang ZY, Takahara N, et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 2000;101:676-81
27. Steinberg HO, Paradisi G, Hook G, et al. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 2000;49:1231-8
28. Arcaro G, Gretti A, Balzano S, et al. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002;105:576-82
29. Wada M, Nagasawa H, Kurita K, et al. Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects. J Neurol Sci 2007;255:27-34
30. Gavras HP. Issues in hypertension: drug tolerability and special populations. Am J Hypertens 2001;14:231-6S
31. Lender D, Arauz-Pacheco C, Breen L, Mora-Mora P, et al. A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients. Am J Hypertens 1999;12:298-303
32. Bianchi S, Bigazzi R, Baldari G, et al. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994;7:23-9
33. Anan F, Takahashi N, Ooie T, et al. Role of insulin resistance in nondipper essential hypertensive patients. Hypertens Res 2003;26:669-76